Potential plasma biomarkers for the onset of heat and skeletal muscle inflammation from Piscine orthoreovirus-1 infection in Atlantic salmon (Salmo salar)

Biomarkers that give quantifiable information about disease development are valuable diagnostic indicators providing opportunities to thwart adverse outcomes through timely detection and initiation of countermeasures. Whereas human medicine already relies extensively on biomarker analysis, their application in the diagnostics of fish diseases is still at a tentative beginning. However, the increased utilisation of broad-range analytical approaches such as untargeted proteomics enhances the chances to discover changes in the levels of proteins, which are connected to fish health and could serve as novel biomarkers. In the present study, proteomic analysis accompanied by biostatistical data processing was employed with the aim of identifying plasma biomarker candidates for the onset of heart and skeletal muscle inflammation (HSMI) caused by Piscine orthoreovirus (PRV)-1 infection in Atlantic salmon. HSMI is a common viral disease and threat to fish welfare and productivity in Norwegian aquaculture, so that the early detection of HSMI development would allow a timely intervention to limit the damage. In the search for biomarker candidates, salmon plasma was sampled five and eight weeks after a PRV-1 cohabitation challenge experiment and from adequate control fish, and analysed by mass spectrometry-based proteomics. The proteome dataset contained 695 proteins with >90% probability of correct identification according to the set cut-off criteria for peptide quality. Time- and condition-related differences in protein abundance levels were revealed by multivariate analysis. Comparison of the proteins identified as significant using three different biostatistical models resulted in a short list of four potential biomarkers: galectin-3-binding protein (Gal-3BP), fucolectin-6, urokinase plasminogen activator surface receptor and ryanodine receptor 3. The physiological functions described for these proteins in mammals designate them as interesting indicators of inflammatory diseases also in other species, such as PRV-1 pathogenesis in salmon. In situ-hybridisation targeting Gal-3BP and PRV-1 mRNA in heart tissue sections from the same challenge trial showed a significant upregulation of Gal-3BP mRNA in infected salmon hearts as compared to controls, supporting the findings of the proteomic analysis and suggesting a role in the onset of heart- and skeletal muscle inflammation.